Back to Search
TIMOTHY YAU, MD
MD
Nephrology Physician
NPI: 1275794729IndividualAccepts Medicare
Specialties, Licenses & Credentials
Nephrology PhysicianPrimary
Internal Medicine — Nephrology
Code: 207RN0300X
2011016773(MO)
Education
SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE
Class of 2005
Research & Publications (20)
Surveillance in stage I seminoma patients: a long-term assessment.
PMID 19545941·Eur Urol·2010
8-other
Age distribution of human papillomavirus infection and cervical neoplasia reflects caveats of cervical screening policies.
PMID 19588497·Int J Cancer·2010
8-other
Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery.
PMID 19379996·J Thorac Cardiovasc Surg·2009
4-observational
Longitudinal assessment of quality of life in rectal cancer patients with or without stomas following primary resection.
PMID 19404073·Dis Colon Rectum·2009
4-observational
HAI-2 is epigenetically downregulated in human hepatocellular carcinoma, and its Kunitz domain type 1 is critical for anti-invasive functions.
PMID 19107935·Int J Cancer·2009
8-other
Large-cell neuroendocrine carcinoma of the uterine cervix complicating pregnancy.
PMID 19197101·Hong Kong Med J·2009
5-case
Human erythrocyte flickering: temperature, ATP concentration, water transport, and cell aging, plus a computer simulation.
PMID 19484468·Eur Biophys J·2009
7-preclinical
Acute kidney injury after cardiac surgery: focus on modifiable risk factors.
PMID 19153273·Circulation·2009
4-observational
Management of advanced hepatocellular carcinoma in the era of targeted therapy.
PMID 19120940·Liver Int·2009
6-review
Hepatocyte-specific activation of NF-kappaB does not aggravate chemical hepatocarcinogenesis in transgenic mice.
PMID 19090486·J Pathol·2009
4-observational
Phase 2 open-label study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population: presence of lung metastasis predicts poor response.
PMID 19107763·Cancer·2009
3-trial
Trends and patterns of breast conservation treatment in Hong Kong: 1994-2007.
PMID 19101091·Int J Radiat Oncol Biol Phys·2009
8-other
Should young age be a contra-indication to breast conservation treatment in Chinese women? Twelve-year experience from a public cancer centre in Hong Kong.
PMID 19342734·Hong Kong Med J·2009
4-observational
Deleted in liver cancer 2 (DLC2) was dispensable for development and its deficiency did not aggravate hepatocarcinogenesis.
PMID 19668331·PLoS One·2009
7-preclinical
Improvement in cardiac function after bone marrow cell thearpy is associated with an increase in myocardial inflammation.
PMID 19011044·Am J Physiol Heart Circ Physiol·2009
7-preclinical
Complications of traditional Chinese/herbal medicines (TCM)--a guide for perplexed oncologists and other cancer caregivers.
PMID 19009311·Support Care Cancer·2009
6-review
Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.
PMID 18922648·Int J Radiat Oncol Biol Phys·2009
8-other
Familial nasopharyngeal carcinoma in Hong Kong: epidemiology and implication in screening.
PMID 18726711·Fam Cancer·2009
8-other
Glutamate racemase dimerization inhibits dynamic conformational flexibility and reduces catalytic rates.
PMID 19552402·Biochemistry·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4921 PARKVIEW PL, DIV IM NEPHROLOGY, STE 5C
SAINT LOUIS, MO 63110 - Phone
- (314) 362-7603
Quick Facts
- NPI
- 1275794729
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 21
- Publications
- 20
Are you this provider?
Claim Your Profile